SM
AYTU icon

Sabby Management’s AYTU BioPharma AYTU Stock Holding History

Sabby Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-63,126
Closed -$234K – 111
2022
Q3 		$234K Buy
+63,126
New +$479K 0.3% 59
2019
Q1 		– Sell
-2,575
Closed -$408K – 87
2018
Q4 		$408K Buy
2,575
+2,398
+1,355% +$528K 0.09% 59
2018
Q3 		$98K Hold
177
– – 0.01% 102
2018
Q2 		$186K Buy
+177
New +$295K 0.03% 102

Other funds holding AYTU

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $305M AUM 26.92% 1-Year Est. Return

Sabby Management's AYTU Position: Q4 2022 in Review

Sabby Management sold out of AYTU BioPharma (AYTU) in Q4 2022, closing a stake of 63,126 shares — an estimated $234K sold.

Sabby Management first reported a position in AYTU in Q2 2018 and held it in 4 quarters. The position peaked at $408K in Q4 2018. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

  • Sabby Management reported no remaining AYTU BioPharma position as of Q4 2022 after selling out during the quarter.
  • Sabby Management sold 63,126 AYTU BioPharma shares in Q4 2022, an estimated $234K.
  • Sabby Management first reported a position in AYTU BioPharma in Q2 2018 and held it in 4 quarters.
  • Sabby Management's AYTU BioPharma position peaked at $408K in Q4 2018.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on Sabby Management's 13F filing for Q4 2022, filed 14 Feb 2023.